Related Experiment Videos

Pathogenetic aspects of hypertension in Cushing's syndrome

Cardiology
|January 1, 1985
PubMed

Insights

Hypertension in Cushing's syndrome may not stem from the renin-angiotensin-aldosterone system (RAAS). Other factors, such as catecholamines, likely play a larger role in blood pressure elevation in these patients.

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine

Background:

  • Cushing's syndrome is characterized by excessive cortisol production.
  • Hypertension is a common comorbidity in Cushing's syndrome.
  • The role of the renin-angiotensin-aldosterone system (RAAS) in this hypertension is not fully understood.

Purpose of the Study:

  • To investigate the abnormalities of the RAAS in patients with Cushing's syndrome.
  • To assess the relationship between RAAS components and hypertension in this cohort.

Main Methods:

  • Studied 12 patients with various causes of Cushing's syndrome.
  • Measured plasma renin substrate, urinary-free cortisol, and circadian rhythms of plasma cortisol, aldosterone, and plasma renin activity.

Main Results:

  • Elevated plasma renin substrate was observed in most patients.
  • Plasma renin activity showed variable levels (elevated, normal, or lowered).
  • Plasma aldosterone levels were in the lower normal range, with episodic secretion.

Conclusions:

  • The RAAS may not be the primary driver of hypertension in Cushing's syndrome.
  • Circulating catecholamines are suggested as a more significant factor in blood pressure elevation.

Related Concept Videos